期刊选题

1、投稿方式：在线投稿。

2、官网网址：

https://www.journals.elsevier.com/genes-and-diseases

3、投稿网址：https://www.editorialmanager.com/GENDIS

4、官网邮箱：editor@genesndiseases.com（编辑部）

5、官网电话：023-65714691（编辑部）

6、出刊日期：双月刊，逢单月出版。

2021年8月30日星期一

《基因与疾病（英文）》投稿指南

【官网信息】

Guide for Authors

About the Journal

Genes

& Diseases is an international journal for molecular and

translational medicine. The journal primarily focuses on publishing

investigations on the molecular bases and experimental therapeutics of

human diseases. Publication formats include full length research

article, review article, short communication, correspondence,

perspectives, commentary, views on news, research watch, letters,

research highlights, and enabling and emerging technologies.

Aims and Scope

Genes

& Diseases publishes rigorously peer-reviewed and high quality

original articles and authoritative reviews that focus on the molecular

bases of human diseases. Emphasis will be placed on hypothesis-driven,

mechanistic studies relevant to pathogenesis and/or experimental

therapeutics of human diseases. The journal has worldwide authorship,

and a broad scope in basic and translational biomedical research of

molecular biology, molecular genetics, and cell biology, including but

not limited to cell proliferation and apoptosis, signal transduction,

stem cell biology, developmental biology, gene regulation and

epigenetics, cancer biology, immunity and infection, neuroscience,

disease-specific animal models, gene and cell-based therapies, and

regenerative medicine.

Editorial Process

All

manuscripts received are duly acknowledged. Upon submission, the

Editorial Office will check the manuscript's conformity to technical

quality and author guidelines, typically within one week. Manuscripts

with insufficient conformity are returned to authors for revision.

Manuscripts with insufficient originality, serious scientific or

experimental flaws, or lack of interest to the readership of Genes &

Diseases will be rejected by the Editor-in-Chief and/or Deputy

Editor-in-Chief without further peer review. Manuscripts deemed suitable

for publication are sent to the Executive Associate Editors. The

Executive Associate Editors will make initial assessment and will serve

as the managing editor, who in turn will appoint 2-3 editorial board

members and/or external referees to complete peer reviews within 4

weeks. Based on the recommendations and comments made by peer reviewers,

the Executive Associate Editor will make a formal recommendation to the

Editor-in-Chief and/or Deputy Editor-in-Chief who will make the final

decision within 1 week, in consultation with other editorial board

members, if deemed necessary. The comments and recommendations

(acceptance/ rejection/ minor revision/ major revision in manuscript)

received from reviewers are conveyed to the corresponding author. If

necessary, the author is required to provide a point by point response

to reviewers' comments and submit a revised manuscript. This process

will be repeated till reviewers and editors are satisfied with the

revised manuscript.

Manuscripts

accepted for publication are copy edited for grammar, punctuation,

print style, and format. Page proofs are sent to the corresponding

author. The corresponding author is expected to return the corrected

proofs within 48 hours. The whole process of submission of the

manuscript, final decision, sending and receiving proofs is completed

online. To achieve faster and greater dissemination of knowledge and

information, the journal publishes articles online as 'Ahead of Print'

immediately upon acceptance.

During

submission, the contributor is requested to provide names of at least

three qualified reviewers who have had experience in the subject of the

submitted manuscript. The reviewers should not be affiliated with the

same institutes as the contributor/s. However, the selection of these

reviewers is at the sole discretion of the editor.

Contact Details for Submission

Papers

should be submitted through the Genes & Diseases online submission

system, https://www.editorialmanager.com/GENDIS. For questions on the

submission and reviewing process, please contact the Editorial Office

at: editor@genesndiseases.com; telephone +86-23-6571 4691.

……

更多详情请查看期刊官网信息：

https://www.elsevier.com/journals/genes-and-diseases/2352-3042/guide-for-authors